Ruicheng Venture Capital

Ruicheng sources proprietary deal flow through long-term relationships with technology transfer offices and faculty labs at institutions including Tsinghua University, Shanghai Jiao Tong University, and the Chinese Academy of Sciences. The firm targets research-stage spinouts that have not yet been formally marketed to the broader venture community. This research-lab channel is the firm's primary differentiator for early access to deep-science founders.

The firm targets seed and Series A stages, with initial checks in the single-digit millions of dollars. Ruicheng reserves capital to follow portfolio companies into later expansion rounds, and maintains a concentrated portfolio with fewer than two dozen active positions at any time. This early-entry, high-conviction posture is suited to technology risk from lab-stage innovation.

Ruicheng does not publicly maintain an explicit avoid list. Based on the firm's disclosed focus areas — applied AI, enterprise software, industrial automation, and healthcare services — the investment strategy effectively excludes consumer internet, content platforms, and asset-heavy industries outside its research-lab sourcing funnel. There is no record of Ruicheng investing in consumer-facing mobile apps or real estate development.